Revenue for the period climbed to 286.65 billion yen, up from 272.39 billion yen reported in the same quarter last year. Operating profit mirrored this growth, reaching 12.01 billion yen compared to 11.65 billion yen, while pretax profit rose to 12.77 billion yen from 12.19 billion yen. Earnings per share saw a marginal increase, landing at 104.11 yen against the previous 103.10 yen. These results were calculated using Japanese accounting standards.
COSMOS Pharmaceutical Posts Modest First-Quarter Gains
With net profit rising to 8.25 billion yen for the quarter ending August 31, COSMOS Pharmaceutical Corp. edged past its previous year performance of 8.17 billion yen. The Japanese drugmaker’s latest financial report reflects steady growth across core metrics, maintaining a consistent upward trajectory in a competitive market environment.
Comments (0)
No comments yet. Be the first!